From OncoWiki
Revision as of 02:18, 7 February 2012 by Palmdoc (talk | contribs) (1 revision)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Rituximab (Rituxan) 375 mg/m2 iv d1
Gemcitabine (Gemzar) 1000 mg/m2 (in 500 ml normal saline) iv at 10 mg/m2/min d2
Oxaliplatin 100 mg/m2 iv over 2 hrs d2
Q2w x 8 cycles


Gnaoui TE et al. Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy. Ann Oncol 2007; Advanced access published May 11, 2007